We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 21.27%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+21.27%
3 Year Est. Return
+58.14%
5 Year Est. Return
+50.47%
10 Year Est. Return
+146.76%
AUM
$2.1B
AUM Growth
+$86.1M
Cap. Flow
-$1.99M
Cap. Flow %
-0.09%
Top 10 Hldgs %
74.28%
Holding
88
New
6
Increased
19
Reduced
38
Closed
9

Sector Composition

Rank Sector Weight
1 Miscellaneous 97.6%
2 Technology 1.57%
3 Financials 0.65%
4 Consumer Staples 0.07%
5 Consumer Discretionary 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
76
ExxonMobil
XOM
$656B
$254K 0.01%
+2,367
New +$258K
GOOGL icon
77
Alphabet (Google) Class A
GOOGL
$4.14T
$227K 0.01%
1,900
-500
-21% -$57.6K
IWR icon
78
iShares Russell Mid-Cap ETF
IWR
$56.9B
$207K 0.01%
2,838
-34,165
-92% -$2.38M
COMP icon
79
Compass
COMP
$8.54B
$77K ﹤0.01%
+21,999
New +$72.1K
APH icon
80
Amphenol
APH
$204B
-16,200
Closed -$331K
BA icon
81
Boeing
BA
$168B
-1,000
Closed -$212K
BLK icon
82
Blackrock
BLK
$174B
-406
Closed -$272K
JNJ icon
83
Johnson & Johnson
JNJ
$663B
-1,674
Closed -$259K
MA icon
84
Mastercard
MA
$507B
-1,461
Closed -$531K
SPGI icon
85
S&P Global
SPGI
$131B
-782
Closed -$270K
TMO icon
86
Thermo Fisher Scientific
TMO
$227B
-1,106
Closed -$637K
UNH icon
87
UnitedHealth
UNH
$356B
-647
Closed -$306K
ZBRA icon
88
Zebra Technologies
ZBRA
$17.2B
-686
Closed -$218K

Similar funds

Hirtle Callaghan & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Hirtle Callaghan & Co held 88 positions worth $2.1B, up 4.3% from $2.01B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Hirtle Callaghan & Co's Q2 2023 filing shows 6 new, 19 increased, 38 reduced and 9 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 90,843 shares worth $10M. The largest sale was Vanguard Morningstar Value ETF, an estimated $16.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, up from 98% a quarter earlier, followed by Technology and Financials.

  • Hirtle Callaghan & Co's largest Q2 2023 buy was iShares 0-1 Year Treasury Bond ETF: 90,843 shares worth $10M.
  • Hirtle Callaghan & Co added most to iShares Core MSCI EAFE ETF in Q2 2023, an estimated $21.8M increase.
  • Hirtle Callaghan & Co's biggest Q2 2023 reduction was Vanguard Morningstar Value ETF, cutting an estimated $16.8M.
  • Hirtle Callaghan & Co fully exited Thermo Fisher Scientific in Q2 2023, selling an estimated $637K.
  • Hirtle Callaghan & Co's ten largest holdings make up 74% of its $2.1B portfolio in Q2 2023.
  • Hirtle Callaghan & Co opened 6 new positions and closed 9 in Q2 2023.
  • Hirtle Callaghan & Co's portfolio value rose 4.3% quarter-over-quarter to $2.1B.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2023, filed 10 Aug 2023.